Mixed chimerism, heart, and skin allograft tolerance in cyclophosphamide-induced tolerance

Transplantation

Volumn 70, Issue 6, 2000, Pages 906-916

  Zhang, Qi Wei ^a   Tomita, Yukihiro ^a,b   Matsuzaki, Goro ^a   Yoshikawa, Masahiro ^a   Shimizu, Ichiro ^a   Nakashima, Yutaka ^a   Sueishi, Katsuo ^a   Nomoto, Kikuo ^a   Yasui, Hisataka ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4;

ALLOGRAFT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHIMERA; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; FEMALE; GENE DELETION; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN ALLOGRAFT; THYMOCYTE;

EID: 0034721491     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200009270-00008     Document Type: Article

References (56)

1. Progress toward transplantation of tissues in man
2. 'Actively acquired tolerance' of foreign cells
3. The importance of chimerism in maintaining tolerance of skin allografts in mice?
4. Successful skin homografts after the administration of high dosage X radiation and homologous bone marrow
5. Histocompatibility studies in a closely bred colony of dogs. IV. Tolerance to bone marrow, kidney, and skin allografts in DLA-identical radiation chimera
6. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts
7. Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: Long-term survival of allogeneic bone marrow and skin grafts
8. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen
9. Alloantigen persistence in induction and maintenance of transplantation tolerance
10. Studies on heterogous anti-lymphocyte serum in mice. III. Immunologic tolerance and chimerism produced across the H-2 locus with adult thymectomy and anti-lymphocyte serum
11. Monoclonal antibodies to promote engraftment and tissue graft tolerance
12. Induction of classical transplantation tolerance in the adult
13. Correlation of intrathymic tolerance with intrathymic chimerism in neonatally tolerized mice
14. Drug-induced tolerance to allografts in mice. I. Difference between tumor and skin grafts
15. Drug induced tolerance to allografts in mice: III. Prolongation of skin graft survival by tolerance induction in congenic mice disparate in the major H-2 antigens
16. Drug-induced tolerance to allografts in mice. IV. Tolerance induction in H-2-haplotype-identical strain combinations in mice
17. Importance of suppressor T cells in cyclophosphamide-induced tolerance to the non-H-2-encoded alloantigens. Is mixed chimerism really required in maintaining a skin allograft tolerance?
18. + T cells in cyclophosphamide-induced tolerance to H-2-compatible, Mls-disparate antigens
19. Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletion
20. Sequential mechanisms of cyclophosphamide-induced skin allograft tolerance including the intrathymic clonal deletion followed by late breakdown of the clonal deletion
21. Fractionated dosing of cyclophosphamide for establishing long-lasting skin allograft survival, stable mixed chimerism, and intrathymic clonal deletion in mice primed with allogeneic spleen cells
22. Prevention of chronic rejection and graft arteriosclerosis by tolerance induction
23. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts
24. Improved technique of heterotopic cervical heart transplantation in mice
25. The blockade of Fc receptor-mediated clearance of immune complexes in vivo by a monoclonal antibody (2.4G2) directed against Fc receptors on murine leukocytes
26. Cardiac transplantation in the rat. I. The effect of histocompatibility differences on graft arteriosclerosis
27. TCR alpha beta+ CD4-CD8- T cells differentiate extrathymically in an lck-independent manner and participate in early response against Listeria monocytogenes infection through interferon-gamma production
28. Mixed allogeneic chimerism as an approach to transplantation tolerance
29. + T cells, mediate the breaking of tolerance in mixed allogeneic chimeras (B10 + B10.BR→B10)
30. The requirement for allogeneic chimerism for second transfer of tolerance from mixed allogeneic chimeras (A+B→A) to secondary recipients
31. Reconstitution ratio is critical for alloreactive T cell deletion and skin graft survival in mixed bone marrow chimeras
32. Additional mAb injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mAns and 3 Gy whole body irradiation
33. Mechanisms by which additional monoclonal antibody injections overcome the requirement for thymic irradiation to achieve mixed chimerism in mice receiving bone marrow transplantation after conditioning with anti-T cell mAbs and 3 Gy whole body irradiation
34. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone
35. Graft coronary disease: The lesions and the patients
36. Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporine and azathioprine regimens
37. Both alloantigen-dependent and -independent factors influence chronic allograft rejection
38. Immune mechanisms in atherosclerosis
39. Growth factors and cell proliferation in human transplant arteriosclerosis
40. Cytokines. Structure, function, and role in immune response amplification
41. Cardiac allograft vasculopathy is abrogated by anti-CD8 monoclonal antibody therapy
42. CD4+ mononuclear cells induce cytokine expression, vascular smooth muscle cell proliferation, and arterial occlusion after endothelial injury
43. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones
44. Gamma-interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro
45. Mitogenic action of interleukin-1 alpha on vascular smooth muscle cells mediated by PDGF
46. Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries
47. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy
48. Prevention of graft coronary arteriosclerosis by antisense cdk2 kinase oligonucleotide
49. Are Th2 helper T lymphocytes beneficial, deleterious, or irrelevant in promoting allograft survival?
50. The Th1/Th2 paradigm and the allograft response
51. IL-2 knockout recipient mice reject islet cell allografts
52. Heart transplants in interferon-gamma, interleukin 4, and interleukin 10 knockout mice. Recipient environment alters graft rejection
53. Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4
54. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes
55. IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways
56. Blocking the CD28-B7 T cell costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4